News
Shane Jacobson: One of the Best Parts of Being CEO of the American Cancer Society
10+ hour, 29+ min ago (159+ words) Shane Jacobson, Chief Executive Officer of the American Cancer Society (ACS) and American Cancer Society Cancer Action Network (ACS CAN), shared a post on Linked In: "One of the best parts of this role is spending time with people who…...
Vincenzo Nasca: CLDN18. 2 Expression Differs Btween Primary and Metastatic Pancreatic Cancer
4+ hour, 27+ min ago (185+ words) Vincenzo Nasca " Memorial Sloan Kettering Cancer Center, United States, presented his poster at ESMO GI 2026. "Hello everyone, my name is Vincenzo Naska. I am an Oncology Fellow at the National Cancer Institute in Milan, and since November I have been…...
Liang Cheng: Paired Tissue and ct DNA Profiling Unlocks New Breast Cancer Resistance Mechanisms - Onco Daily
1+ hour, 42+ min ago (289+ words) Liang Cheng: Paired Tissue and ct DNA Profiling Unlocks New Breast Cancer Resistance Mechanisms Oncodaily Liang Cheng: Paired Tissue and ct DNA Profiling Unlocks New Breast Cancer Resistance Mechanisms Liang Cheng, President of International Society of Urological Pathology, Vice Chair…...
Gabor Liposits: State-of-the-Art Management of Colorectal Cancer in Older Adults Presented at ESMO GI 2026 - Onco Daily
5+ hour, 5+ min ago (156+ words) Gabor Liposits: State-of-the-Art Management of Colorectal Cancer in Older Adults Presented at ESMO GI 2026 / cancer, Capucine Baldini, colorectal cancer, , cancer, Capucine Baldini, colorectal cancer, David Sebag-Montefiore, Demetris Papmichael, ESMO GI 2026, Gabor Liposits, Onco Daily, Oncology, SIOG - International Society of Geriatric…...
Sheraz Azhar: The HER2-Targeted ADC Landscape Continues to Evolve - Onco Daily
1+ hour, 49+ min ago (232+ words) Sheraz Azhar, Medical Oncology Sp R at the University Hospitals of Leicester NHS Trust and Founder of Oncs Care, shared a post on Linked In: "The HER2-targeted ADC landscape continues to evolve. A phase III trial published in The Lancet…...
Narjust Florez: What Happens at ELIXR 2026 Shapes Tomorrow's Lung Cancer Research - Onco Daily
2+ hour, 54+ min ago (94+ words) Onco Daily is a specialized news and information platform that provides daily updates on oncology research, treatments, clinical trials, and advancements in cancer care. It serves healthcare professionals, researchers, and patients by delivering timely and accurate insights into the latest…...
New Evidence-Based Guideline to Standardize Bone Cancer Imaging - Princess M'xima Center - Onco Daily
7+ hour, 39+ min ago (203+ words) Prinses M'xima Centrum voor kinderoncologie (Princess M'xima Center) shared a post on Linked In: "A new evidence-based guideline will help standardize imaging in children and adults with bone cancer. Prof. Hans Merks, who led the study: "We found that many…...
Marie Olivier Appointed Senior Vice President, Head of Global Development Operations at Bristol Myers Squibb - Onco Daily
2+ hour, 15+ min ago (156+ words) Marie Olivier, Senior Vice President, Global Head of Global Development Operations at Bristol Myers Squibb, shared a post on Linked In: "I am thrilled to announce that I have joined Bristol Myers Squibb as Senior Vice President, Head of Global…...
Kefah Mokbel: MRI-Guided De-Escalation in HER2-Positive Early Breast Cancer - Onco Daily
1+ hour, 55+ min ago (124+ words) Kefah Mokbel, Chair of Breast Cancer Surgery at London Breast Institute and Honorary Professor of Medicine at Cardiff University School of Medicine, shared a post on Linked In: Delighted to share our latest Editorial Commentary, published today in Translational Breast…...
Jame Abraham: GLP-1 Receptor Agonists in Breast Cancer Care and Survivorship - Onco Daily
2+ hour, 12+ min ago (233+ words) Jame Abraham: GLP-1 Receptor Agonists in Breast Cancer Care and Survivorship / Baidehi Maiti, Breast Cancer, cancer, Jame Abraham, Jasmin Hunda, Jasmin, Baidehi Maiti, Breast Cancer, cancer, Jame Abraham, Jasmin Hunda, Jasmin Hundal, Keren Zhou, Marguerite Linz, obesity, Onco Daily, Oncology,…...